Regionally expressed cell surface molecules are thought to mediate contactdependent interactions that regulate pattern formation and axon pathfinding in the developing vertebrate central nervous system (CNS). We recently isolated monoclonal antibody (mAb) CARO 2 through a screen for positional markers in the developing rat CNS. Between embryonic day (E)11.5 and E13, mAb CARO 2 specifically labels both the floor plate and notochord in the developing spinal cord. In contrast to the distribution of several well-characterized ventral midline markers, mAb CARO 2 labeling is restricted to the apical portion of the floor plate and the outer surface of the notochord. The anterior limit of mAb CARO 2 immunoreactivity corresponds to the midbrain/hindbrain border. Floor plate labeling persists throughout embryogenesis, whereas notochord labeling is not detectable after E13. During later stages of embryonic development (E16-E20) apically restricted floor plate labeling is present only in the rostral spinal cord. In postnatal rats, mAb CARO immunoreactivity is not present in any region of the CNS. Immunoblot analyses show that mAb CARO 2 recognizes an epitope on a 28-kD protein that is enriched in the floor plate, transiently expressed during embryogenesis, and membrane-associated. Consistent with the latter result, mAb CARO 2 labels the surfaces of floor plate cells. These findings suggest that the CARO 2 antigen is a new cell surface marker of the floor plate and notochord which may participate in neural cell patterning and/or axon guidance in the developing rat spinal cord.